AC Immune SA 于AD/PD™ 2026会议上,首次展示了其PET示踪剂ACI-19626在一期临床试验中获得的脑内TDP-43病理学活体影像。这一突破性进展为神经退行性疾病的研究提供了新的可视化工具。
AC Immune SA 于AD/PD™ 2026会议上,首次展示了其PET示踪剂ACI-19626在一期临床试验中获得的脑内TDP-43病理学活体影像。这一突破性进展为神经退行性疾病的研究提供了新的可视化工具。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.